Author:
Hur Joon Young,Chao Joseph,Kim Kyung,Kim Seung Tae,Kim Kyoung-Mee,Klempner Samuel J.,Lee Jeeyun
Funder
Korean Health Technology R&D Project
Ministry of Health & Welfare, Republic of Korea
Subject
Cell Biology,Pathology and Forensic Medicine
Reference21 articles.
1. Biomarkers for gastric cancer: molecular classification revisited;Lee;Precis Future Med,2017
2. Amplification of FGFR2 gene in patients with advanced gastric Cancer Receiving chemotherapy: prevalence and prognostic significance;Shoji;Anticancer Res.,2015
3. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial;Fuchs;Lancet (London, England),2014
4. Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial;Wilke;Lancet Oncol.,2014
5. AZD2171 shows potent antitumor activity against gastric cancer over-expressing fibroblast growth factor receptor 2/keratinocyte growth factor receptor;Takeda;Clin. Cancer Res.,2007
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献